Circulating tumor cells in breast cancer

Area of Science:

• Oncology
• Molecular Biology
• Biomarkers

Background:

• Circulating tumor cells (CTCs) are shed from primary tumors into the bloodstream.
• Accurate detection and characterization of CTCs are crucial for cancer management.
• Current research focuses on refining CTC detection methods and understanding their clinical utility.

Purpose of the Study:

• To review recent advancements in the detection and characterization of CTCs in breast cancer.
• To evaluate the prognostic significance of CTCs in various breast cancer settings.
• To explore the potential of CTCs as a tool for personalized therapy.

Main Methods:

• Review of current literature on CTC detection and characterization in breast cancer.
• Analysis of studies utilizing various methods and markers for CTC identification.
• Evaluation of data on the prognostic value of CTC monitoring.

Main Results:

• CellSearch system data support prognostic value of CTC monitoring in metastatic breast cancer undergoing chemotherapy.
• Detection of cytokeratin 19 mRNA-positive cells predicts worse outcomes in early breast cancer, particularly triple-negative and HER2-positive subtypes.
• Gene-expression profiling of single CTCs is feasible and holds promise for targeted therapies.
• CTC phenotyping may predict treatment response in pilot studies.

Conclusions:

• CTCs show potential as a prognostic tool for both early and metastatic breast cancer.
• CTC phenotyping and profiling can serve as a real-time tumor biopsy for personalized targeted therapies.